EN
HI
Summary
As of 4 Sep, 2026, Kilitch Drugs (India) stock price is ₹172.52. During the trading session, the stock has moved between an intraday low of ₹167.00 and an intraday high of ₹173.71. Over the last 52 weeks, Kilitch Drugs (India) has traded between ₹117.25 and ₹219.50.
The stock has recorded a trading volume of 8,770 shares, with a market capitalization of ₹34961564. Its Average Traded Price (ATP) is ₹171.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 33 @ ₹172.52.
Kilitch Drugs (India) has an upper circuit limit of ₹181.14 and a lower circuit limit of ₹163.90. The total value traded stands at ₹15.01 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Kilitch Drugs (India) also offers a dividend yield of 0%.
Kilitch Drugs (India) share price chart
Kilitch Drugs (India) Share Key Metrics
Volume
8770.00
Market Cap
603.16 CR
LTQ@LTP
33@172.52
ATP
171.1
Var Margin
100 %
Circuit Range
163.9-181.14
Delivery %
0 %
Value
15.01 L
ASM/GSM
No
Market Lot
1
Kilitch Drugs (India) Fundamentals
P/E Ratio
19.96
P/B Ratio
2.13
Div. Yield
0
Sector P/E
41.75
Sector P/B
3.57
Sec. Div. Yield
0.5
Kilitch Drugs (India) Resistance and Support
Pivot 171.08
Resistance
First Resistance
175.16
Second Resistance
177.79
Third Resistance
181.87
Support
First Support
168.45
Second Support
164.37
Third Support
161.74
Kilitch Drugs (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 03 2026 | 167 | 172.52 | 0.68% | 173.71 | 167 |
| Wed Sep 02 2026 | 170.6 | 171.36 | 0.47% | 172.39 | 166.14 |
| Tue Sep 01 2026 | 175.5 | 170.55 | -2.34% | 175.99 | 170 |
Kilitch Drugs (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-07-02 | Others |
Kilitch Drugs (India) News
Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Kilitch Drugs' Monitoring Agency Report for the quarter ended June 30, 2026, confirms no deviation in the utilization of funds raised through its Rs. 49.92 crore rights issue. A minor delay in utilizing Rs. 1.12 crore for general corporate purposes has since been resolved.
Aug 18 2026 23:17:04
Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Financial Results For The Quarter Ended 30Th June 2026
Kilitch Drugs board approved Q1 FY27 results on August 13, 2026. Consolidated revenue increased by 4.57% YoY to ₹47.78 cr, though net profit declined by 12.92% YoY to ₹1.97 cr. Standalone net profit for the quarter rose by 5.43% YoY to ₹5.05 cr.
Aug 13 2026 21:04:12
Read More
Kilitch Drugs (India) Management
| Name | Position |
|---|---|
| Pushpa Nyoupane | Company Secretary & Compliance Officer |
| Mukund P Mehta | Managing Director |
Kilitch Drugs (India) Similar Stocks
Albert David Ltd.
870.15
0.00 (0.00%)
Bafna Pharmaceuticals Ltd.
301.85
0.00 (0.00%)
Zim Laboratories Ltd.
128.02
0.00 (0.00%)
Influx Healthtech Ltd.
290.40
0.00 (0.00%)
Osel Devices Ltd.
383.90
0.00 (0.00%)
Accent Microcell Ltd.
607.40
0.00 (0.00%)
Valiant Laboratories Ltd.
100.93
0.00 (0.00%)
Chandan Healthcare Ltd.
208.95
0.00 (0.00%)
Kilitch Drugs (India) FAQs
The Buying Price of Kilitch Drugs (India) share is 172.52 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 19.96. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 2.13. Useful to assess the stock's value relative to its book value.
To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 41.75 & 3.57 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kilitch Drugs (India) is 603.16 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kilitch Drugs (India) share price is 219.50 & 117.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kilitch Drugs (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
